Anti-ERG antibody [EPR3864],Abcam,AB92513

Anti-ERG antibody [EPR3864] (ab92513) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P and WB. Anti-ERG antibody [EPR3864] (ab92513) was first used in a scientific publication in 2010 and has been cited over 238 times in peer reviewed journals. It's performance in IHC in mouse and human samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-ERG antibody [EPR3864] (ab92513) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-ERG antibody [EPR3864] (ab92513) has 17 independent reviews from customers. Anti-ERG antibody [EPR3864] (ab92513) specifically detects ERG (UniProt ID: P11308; Molecular weight: 54kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR3864 - ab214796 . Antibody clone EPR3864 is also available pre-conjugated to a variety of labels for your convenience - HRP, Alexa Fluor ® 647, Alexa Fluor ® 488, PE, APC ( ab195514 , ab196149 , ab196374 , ab314261 , ab315146 ). ERG is a transcription factor involved in various cancers, including prostate cancer, where it is often overexpressed due to gene fusions. It plays a crucial role in tumor progression and metastasis, making it a potential target for therapeutic interventions. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .